CRISPR Therapeutics AG (CRSP) EBT Margin Growth (3y) (2019 - 2026)
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) EBT Margin Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -77,617.00 |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 4.49 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 28,548.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 146,420.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -2.39 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 119,010.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 515.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 1,380.00 |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -77,617.00 |
| Mar 31, 2026 | -832,219.00 |
| Dec 31, 2025 | 200.41 Mn |
| Sep 30, 2025 | 17.44 Mn |
| Jun 30, 2025 | 9.05 Mn |
| Mar 31, 2025 | 308,794.00 |
| Dec 31, 2024 | 89,439.00 |
| Sep 30, 2024 | 137,283.00 |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | -210,117.00 |
| Dec 31, 2023 | 3.11 Mn |
| Jun 30, 2023 | 18.01 Mn |
| Mar 31, 2023 | 4.41 Mn |
| Dec 31, 2022 | -202.29 Mn |
| Sep 30, 2022 | -18.64 Mn |
| Jun 30, 2022 | -9.69 Mn |
| Mar 31, 2022 | -394,919.00 |
| Dec 31, 2021 | 4.01 Mn |
| Sep 30, 2021 | -652,045.00 |
| Jun 30, 2021 | 360,350.00 |